SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-19-001853
Accepted
2019-08-12 05:16:50
Documents
1
Effectiveness Date
2019-08-09
Registration Form
F-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 588
  Complete submission text file 9999999995-19-001853.txt   1694
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: EFFECT | Act: 33 | File No.: 333-233063 | Film No.: 191014288
SIC: 2834 Pharmaceutical Preparations